Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

Oxford Biomedica PLC - Filing #5242757

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Disclosure of effect of changes in foreign exchange rates [text block]
Disclosure of information when currency is not exchangeable into another currency [text block]
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]
Disclosure of summarised financial information about foreign operation [text block]
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets
244, 676 GBP
73,385,000 GBP
Current assets
215,504,000 GBP
163,844,000 GBP
Non-current liabilities
164,325,000 GBP
16,584,000 GBP
Current liabilities
59, 663 GBP
33,307,000 GBP
Revenue
139, 989 GBP
142,797,000 GBP
Profit (loss)
GBP
GBP
45,159,000 GBP
39 ,157 GBP
6, 002 GBP
GBP
39,157,000 GBP
GBP
GBP
GBP
19 ,011 GBP
19, 011 GBP
19 ,011 GBP
Other comprehensive income
GBP
GBP
10,575,000 GBP
GBP
2,750,000 GBP
GBP
7 ,825 GBP
GBP
7 ,825 GBP
GBP
Comprehensive income
GBP
GBP
34,584,000 GBP
39,157,000 GBP
3,252,000 GBP
GBP
31,332,000 GBP
GBP
7 ,825 GBP
GBP
GBP
GBP
19, 011 GBP
GBP
GBP
GBP
19 ,011 GBP
19,011,000 GBP

Talk to a Data Expert

Have a question? We'll get back to you promptly.